ProShare Advisors
ZY

ProShare Advisors’s Zymergen Inc. Common Stock ZY Stock Holding History

ProShare Advisors’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,032
Closed -$44K – 2249
2022
Q1 		$44K Sell
15,032
-2,432
-14% -$10.3K ﹤0.01% 2122
2021
Q4 		$117K Buy
+17,464
New +$170K ﹤0.01% 2177

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

ProShare Advisors's ZY Position: Q2 2022 in Review

ProShare Advisors sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 15,032 shares — an estimated $44K sold.

ProShare Advisors first reported a position in ZY in Q4 2021 and held it in 2 quarters. The position peaked at $117K in Q4 2021. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

  • ProShare Advisors reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 15,032 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $44K.
  • ProShare Advisors first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • ProShare Advisors's Zymergen Inc. Common Stock position peaked at $117K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.